Service Cerashield Endotracheal Tube

The main advantage of the Cerashield endotracheal tube is that it is able to reduce or prevent fouling of the device, which is a key factor in the development of potentially lethal respiratory infections. FDA has designated the device as a “breakthrough device” and it is approved for use in Canada, Brazil, and Colombia. We will be seeking CE mark next year.

Looking for companies with a history of developing and commercializing innovative products with a prominent market position. We are open to field of use licensing, geographic rights, and outright sale for certain applications.

Corporation

Our Cerashield ETT is one of many medical devices that we are developing with the same platform technology. We are currently working on coating orthopedic implants, pacemaker envelope, vascular access (PICC lines) and hemodialysis catheters. Any medical device that is in contact with the patient for more than 4 hours is at risk of developing antibiotic resistant biofilms on its surfaces.